Ipca Laboratories Ltd. (IPCALAB): Ipca Laboratories Share Price hits fresh 52-week high as stock rises 1.22%
- August 25, 2026
- Posted by: Harsh Piplani
- Category: News
Ipca Laboratories Share Price moved to Rs 1,944.8 on 25 August 2026, up 1.22% from the previous close, after touching a fresh 52-week high of Rs 1,958. The company’s market capitalisation stands at Rs 48,468.92 crore, placing the move in a large-value context for Healthcare investors tracking Ipca Laboratories Share Price Today and Ipca Laboratories Stock News on Univest. The session confirms a yearly high event, but the supplied data does not establish a company-specific catalyst. What it does show is a clear price event supported by exact market data, along with valuation and profitability ratios that help frame Ipca Laboratories Share Price News today.
Ipca Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,944.8 |
| Previous Close | Rs 1,921.3 |
| Today's Move | +Rs 23.5 (+1.22%) |
| Open | Rs 1,924.85 |
| High | Rs 1,958 |
| Low | Rs 1,910.75 |
| Turnover | Rs 4.31 crore |
| Market Capitalisation | Rs 48,468.92 crore |
Ipca Laboratories Ltd. (IPCALAB) traded at Rs 1,944.8 versus the previous close of Rs 1,921.3, a rise of 1.22%. The stock opened at Rs 1,924.85, reached a high of Rs 1,958 and touched a low of Rs 1,910.75.
Ipca Laboratories Share Price opened at Rs 1,924.85, moved between Rs 1,910.75 and Rs 1,958, and settled at Rs 1,944.8. That leaves the stock Rs 23.5 above the previous close of Rs 1,921.3, which equals a 1.22% gain for the day. The fresh 52-week high of Rs 1,958 was also the session high, so the stock finished just below that level after marking the yearly high. Turnover stood at Rs 4.31 crore, showing the exact value transacted during the session. For readers following Ipca Laboratories Share Price Live and Ipca Laboratories Share Price Update, the day’s action is straightforward: a positive close, a new one-year high, and a finish near the top of the session range.
The key verification point in today’s Ipca Laboratories Share Price Today move is that the market has now printed a fresh 52-week peak, and the next step is to assess whether the company’s financial quality and valuation metrics justify that level of attention.
Ipca Laboratories Ltd. (IPCALAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 48,468.92 crore |
| P/E Ratio | 37.22x |
| P/B Ratio | 5.75x |
| ROE | 15.88% |
| ROCE | 19.41% |
| EPS | Rs 51.63 |
| Book Value Per Share | Rs 334.38 |
| Dividend Yield | 0.31% |
Ipca Laboratories Ltd. (IPCALAB) fundamental metrics show P/E 37.22x, P/B 5.75x, ROE 15.88%, ROCE 19.41%. These figures provide context only and are not a buy or sell signal.
Ipca Laboratories Ltd. has a market capitalisation of Rs 48468.92 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 37.22x, P/B at 5.75x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 15.88% and ROCE of 19.41%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 51.63, book value per share of Rs 334.38, dividend yield of 0.31%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 30.49x, median ROE of 11.81%, median ROCE of 13.75%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 37.22x |
| Benchmark Median P/E | 30.49x |
| Benchmark Average P/E | 46.77x |
| Benchmark P/E Range | 2.94x to 717.43x |
| Company P/B Ratio | 5.75x |
| Benchmark Median P/B | 2.67x |
| Company ROE | 15.88% |
| Benchmark Median ROE | 11.81% |
| Company ROCE | 19.41% |
| Benchmark Median ROCE | 13.75% |
| Company Market Capitalisation | Rs 48,468.92 crore |
| Benchmark Median Market Cap | Rs 575.35 crore |
Ipca Laboratories Ltd. (IPCALAB) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Ipca Laboratories Ltd. (IPCALAB) has a P/E ratio of 37.22x, which is above the benchmark median of 30.49x, a difference of +22.07%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Ipca Laboratories Ltd. (IPCALAB) has a ROE of 15.88%, which is above the benchmark median of 11.81%, a difference of +34.46%. Ipca Laboratories Ltd. (IPCALAB) has a ROCE of 19.41%, which is above the benchmark median of 13.75%, a difference of +41.16%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Anthem Biosciences Ltd. | ANTHEM | 49,101.01 | 86.41 | 15.9 | 21.98 | 29.62 |
| Glaxosmithkline Pharmaceuticals Ltd. | GLAXO | 49,120.97 | 46.48 | 19.7 | 48.76 | 66.79 |
| Gland Pharma Ltd. | GLAND | 46,527.2 | 40.95 | 4.35 | 10.56 | 14.96 |
| Ajanta Pharma Ltd. | AJANTPHARM | 45,489.46 | 39.36 | 9.2 | 25.42 | 32.67 |
| Abbott India Ltd. | ABBOTINDIA | 55,769.96 | 34.76 | 10.84 | 34.67 | 46.72 |
Ipca Laboratories Ltd. (IPCALAB) has a P/E ratio of 37.22x compared with the displayed peer median of 40.95x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 15.88% compares with a peer median of 25.42% across the companies shown in the table. ROCE stood at 19.41% versus the displayed peer median of 32.67%, providing a capital-efficiency comparison. Ipca Laboratories Ltd. (IPCALAB) has a market capitalisation of Rs 48,468.92 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching Ipca Laboratories
- Ipca Laboratories Share Price closed at Rs 1,944.8 after touching a fresh 52-week high of Rs 1,958.
- The day’s move was Rs 23.5, equal to a 1.22% rise from the previous close of Rs 1,921.3.
- Market capitalisation stands at Rs 48,468.92 crore, which is well above the same-industry median quoted in the sector snapshot.
- EPS is Rs 51.63, book value is Rs 334.38 and dividend yield is 0.31% on the supplied data.
- P/E at 37.22, ROE at 15.88% and ROCE at 19.41% give Ipca Laboratories Fundamental Analysis a clear valuation and profitability context.
About Ipca Laboratories
Ipca Laboratories Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied data classifies it within that framework for both NSE and BSE market tracking. On the verified figures in this article, the business profile is best understood through its market capitalisation, profitability ratios and financial results rather than through unsupported operating detail. For readers following Ipca Laboratories Share Price, the company sits inside a broad healthcare peer universe with extensive listed-company comparison coverage on Univest.
Track Ipca Laboratories Share Price on Univest
Use Ipca Laboratories Ltd. (IPCALAB) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Readers can track Ipca Laboratories Share Price on Univest for live share price updates, key financial ratios, shareholding pattern, 52-week levels, peer context and market insights. Univest also presents Ipca Laboratories Stock News, Ipca Laboratories Latest News and Ipca Laboratories Share Price Today in a format designed for quick comparison and deeper stock analysis.
For anyone monitoring Ipca Laboratories Share Price News, the main takeaway is simple: today’s move confirms a fresh 52-week high, while valuation, earnings and sector comparison provide the factual backdrop. Univest will continue to track Ipca Laboratories Share Price, Ipca Laboratories Stock Performance and Ipca Laboratories Share Price Update as new verified data is published.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Ipca Laboratories Share Price hit a fresh 52-week high?
Ans. Ipca Laboratories Share Price touched Rs 1,958 during the session and closed at Rs 1,944.8, marking a fresh 52-week high. The supplied data confirms the price event but does not establish a company-specific catalyst.
What is Ipca Laboratories Share Price today?
Ans. Ipca Laboratories Share Price today is Rs 1,944.8, up Rs 23.5 or 1.22% from the previous close of Rs 1,921.3. The stock also made a fresh 52-week high at Rs 1,958.
What is the market capitalisation of Ipca Laboratories?
Ans. Ipca Laboratories has a market capitalisation of Rs 48,468.92 crore. That places Ipca Laboratories Share Price in a high-value context within the Healthcare sector and the Pharmaceuticals & Drugs industry comparison set.
How do Ipca Laboratories valuation ratios look?
Ans. Ipca Laboratories Share Price trades at a P/E of 37.22 and a P/B of 5.75. These numbers are above the industry median in the supplied benchmark, so valuation needs to be read with the peer context.
What do ROE and ROCE show for Ipca Laboratories?
Ans. Ipca Laboratories reports ROE of 15.88% and ROCE of 19.41%. Both are above the same-industry medians in the supplied sector snapshot, which gives Ipca Laboratories Share Price useful profitability context.
What are the EPS and book value for Ipca Laboratories?
Ans. EPS is Rs 51.63 and book value is Rs 334.38. EPS reflects earnings attributable to each share, while book value shows the accounting net worth behind each share for Ipca Laboratories Share Price analysis.
What is the dividend yield for Ipca Laboratories?
Ans. Ipca Laboratories shows a dividend yield of 0.31%. This is historical or current payout data relative to the share price, and it adds another layer to Ipca Laboratories Share Price analysis.
How does Ipca Laboratories compare with healthcare peers?
Ans. Ipca Laboratories Share Price has a market cap close to Anthem Biosciences and Glaxosmithkline Pharmaceuticals, while its P/E is lower than both in the supplied peer set. Its ROE and ROCE sit mid-pack versus the named peers.
What does the sector snapshot indicate for Ipca Laboratories?
Ans. The sector snapshot places Ipca Laboratories Share Price above the industry median on P/E, P/B, ROE and ROCE. It also shows a market cap well above the same-industry median and average figures.
Where can investors track Ipca Laboratories Share Price news?
Ans. Investors can track Ipca Laboratories Share Price on Univest for live updates, financial ratios, shareholding pattern and 52-week levels. The platform also consolidates Ipca Laboratories Stock News and latest market context.
